Globus Medical (GMED)
NYSEHealth CareMedical - DevicesSnapshot 2026-09-04
$78.29+0.22%
Close 2026-09-04 · 1-day change
NYSEHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · GMED
Next print, the company's guidance track record, and the earnings events we've seen in the last few years.
Likelihood the company beats analyst consensus on its next print. Read from its own beat history plus how sector peers have been reporting. Not a price-direction call: a serial beater often has the beat already priced in.
Prints it beat consensus, recent quarters.
Indicative, not a guarantee. Base rate ~71%.
Industry peers that beat since this name last reported.
Management's most recent EPS guidance action.
expected = 0.35*own_median(12.7) + peer(0.2*0.4) + term(2.0) → 6.51% (capped ±15.0)
Average absolute move on past earnings days.
Annualized: recent baseline volatility.
Of the last 0 guided quarters.
Actual vs. guided EPS, signed.
Excess return vs. sector ETF, day after print.
Earnings prints and pre-announcements detected in the SEC filing stream.
Results of Operations and Financial Condition. On August 6, 2026, Globus Medical, Inc. (the “Company”) issued a press release reporting, among other things, its sales and operating results for the three and six month period ended June 30, 2026. A copy of the press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. In accordance with general instruction B.2 to Form 8-K, the information included in this Item 2.02, and the exhibit attached hereto, shall be dee…
Quarterly EPS and revenue actuals vs. consensus across the last eight quarters (including beat/miss size and the forward consensus heading into the next print) are on the way.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Results of Operations and Financial Condition. On May 7, 2026, Globus Medical, Inc. (the “Company”) issued a press release reporting, among other things, its sales and operating results for the three-month period ended March 31, 2026. A copy of the press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. In accordance with general instruction B.2 to Form 8-K, the information included in this Item 2.02, and the exhibit attached hereto, shall be deemed to be…
Results of Operations and Financial Condition. On February 24, 2026, Globus Medical, Inc. (the “Company”) issued a press release reporting, among other things, its sales and operating results for the three and twelve-month periods ended December 31, 2025. A copy of the press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. In accordance with general instruction B.2 to Form 8-K, the information included in this Item 2.02, and the exhibit attached hereto, s…
Results of Operations and Financial Condition. On January 7, 2026, Globus Medical, Inc. (the “Company”) issued a press release reporting the Company’s preliminary unaudited net sales results for the three-month period and fiscal year ended December 31, 2025. The press release also included preliminary guidance for certain financial measures for the fiscal year ending December 31, 2026. A copy of the press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. I…
Results of Operations and Financial Condition. On November 6, 2025, we issued a press release reporting, among other things, our sales and operating results for the three and nine month period ended September 30, 2025. A copy of the press release is furnished as Exhibit 99.1 to this report. In accordance with general instruction B.2 to Form 8-K, the information included in this Item 2.02, and the exhibits attached hereto, shall be deemed to be “furnished” and shall not be deemed to be “filed”…
Results of Operations and Financial Condition. On August 7, 2025, we issued a press release reporting, among other things, our sales and operating results for the three and six month period ended June 30, 2025. A copy of the press release is furnished as Exhibit 99.1 to this report. In accordance with general instruction B.2 to Form 8-K, the information included in this Item 2.02, and the exhibits attached hereto, shall be deemed to be “furnished” and shall not be deemed to be “filed” with th…
Results of Operations and Financial Condition. On July 21, 2025, Globus Medical, Inc. (the “Company”) issued a press release including preliminary sales results for the second quarter ending June 30, 2025 and other information described in
Results of Operations and Financial Condition. On May 8, 2025, we issued a press release reporting, among other things, our sales and operating results for the three-month period ended March 31, 2025. A copy of the press release is furnished as Exhibit 99.1 to this report. In accordance with general instruction B.2 to Form 8-K, the information included in this Item 2.02, and the exhibits attached hereto, shall be deemed to be “furnished” and shall not be deemed to be “filed” with the Securiti…
Results of Operations and Financial Condition. On February 20, 2025, we issued a press release reporting, among other things, our sales and operating results for the three- and twelve-month periods ended December 31, 2024. A copy of the press release is furnished as Exhibit 99.1 to this report. In accordance with general instruction B.2 to Form 8-K, the information included in this Item 2.02, and the exhibits attached hereto, shall be deemed to be “furnished” and shall not be deemed to be “fi…
Results of Operations and Financial Condition. On January 8, 2025, we issued a press release reporting our preliminary unaudited net sales results for the three-month period and fiscal year ended December 31, 2024. The press release also included preliminary guidance for certain financial measures for the 2025 fiscal year. A copy of the press release is furnished as Exhibit 99.1 to this report. In accordance with general instruction B.2 to Form 8-K, the information included in this Item 2.02,…
Results of Operations and Financial Condition. On November 5, 2024, we issued a press release reporting, among other things, our sales and operating results for the three-month period ended September 30, 2024. A copy of the press release is furnished as Exhibit 99.1 to this report. In accordance with general instruction B.2 to Form 8-K, the information included in this Item 2.02, and the exhibits attached hereto, shall be deemed to be “furnished” and shall not be deemed to be “filed” with the…
Results of Operations and Financial Condition. On August 6, 2024, we issued a press release reporting, among other things, our sales and operating results for the three-month period ended June 30, 2024. A copy of the press release is furnished as Exhibit 99.1 to this report. In accordance with general instruction B.2 to Form 8-K, the information included in this Item 2.02, and the exhibits attached hereto, shall be deemed to be “furnished” and shall not be deemed to be “filed” with the Securi…
Results of Operations and Financial Condition. On May 7, 2024, we issued a press release reporting, among other things, our sales and operating results for the three-month period ended March 31, 2024. A copy of the press release is furnished as Exhibit 99.1 to this report. In accordance with general instruction B.2 to Form 8-K, the information included in this Item 2.02, and the exhibits attached hereto, shall be deemed to be “furnished” and shall not be deemed to be “filed” with the Securiti…